Recap: MeiraGTx Hldgs Q4 Earnings
$MGTX
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
MeiraGTx Hldgs (NASDAQ:MGTX) reported its Q4 earnings results on Thursday, March 14, 2024 at 08:30 AM.
Here's what investors need to know about the announcement.
Earnings
MeiraGTx Hldgs beat estimated earnings by 482.0%, reporting an EPS of $0.42 versus an estimate of $-0.11.
Revenue was up $7.33 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.19 which was followed by a 2.0% increase in the share price the next day.
Here's a look at MeiraGTx Hldgs's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.55 | -0.56 | -0.66 | -0.49 |
| EPS Actual | -0.74 | -0.53 | -0.62 | -0.58 |
| Revenue Estimate | 3.27M | 4.17M | 4.86M | 8.92M |
| Revenue Actual | 5.10M | 3.54M | 3.33M | -5M |
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for MeiraGTx Hldgs visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.